Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Generating West Nile Virus from an Infectious Clone.

Vandergaast R, Fredericksen BL.

Methods Mol Biol. 2016;1435:29-43. doi: 10.1007/978-1-4939-3670-0_4.

PMID:
27188548
2.

In vitro and in vivo characterization of a West Nile virus MAD78 infectious clone.

Hussmann KL, Vandergaast R, Ochsner SP, Huang AC, Gale M Jr, Fredericksen BL.

Arch Virol. 2014 Nov;159(11):3113-8. doi: 10.1007/s00705-014-2176-2. Epub 2014 Jul 15.

3.

Structural proteins of West Nile virus are a major determinant of infectious particle production and fitness in astrocytes.

Hussmann KL, Vandergaast R, Zheng K, Hoover LI, Fredericksen BL.

J Gen Virol. 2014 Sep;95(Pt 9):1991-2003. doi: 10.1099/vir.0.065474-0. Epub 2014 Jun 11.

4.

Generation of West Nile virus infectious clones containing amino acid insertions between capsid and capsid anchor.

Vandergaast R, Hoover LI, Zheng K, Fredericksen BL.

Viruses. 2014 Apr 9;6(4):1637-53. doi: 10.3390/v6041637.

5.

IFN-dependent and -independent reduction in West Nile virus infectivity in human dermal fibroblasts.

Hoover LI, Fredericksen BL.

Viruses. 2014 Mar 24;6(3):1424-41. doi: 10.3390/v6031424.

6.

Differential induction of CCL5 by pathogenic and non-pathogenic strains of West Nile virus in brain endothelial cells and astrocytes.

Hussmann KL, Fredericksen BL.

J Gen Virol. 2014 Apr;95(Pt 4):862-7. doi: 10.1099/vir.0.060558-0. Epub 2014 Jan 10.

7.

The neuroimmune response to West Nile virus.

Fredericksen BL.

J Neurovirol. 2014 Apr;20(2):113-21. doi: 10.1007/s13365-013-0180-z. Epub 2013 Jul 11. Review.

8.

Differential replication of pathogenic and nonpathogenic strains of West Nile virus within astrocytes.

Hussmann KL, Samuel MA, Kim KS, Diamond MS, Fredericksen BL.

J Virol. 2013 Mar;87(5):2814-22. doi: 10.1128/JVI.02577-12. Epub 2012 Dec 26.

9.

West Nile virus (WNV) replication is independent of autophagy in mammalian cells.

Vandergaast R, Fredericksen BL.

PLoS One. 2012;7(9):e45800. doi: 10.1371/journal.pone.0045800. Epub 2012 Sep 21.

10.

Identification of multiple RIG-I-specific pathogen associated molecular patterns within the West Nile virus genome and antigenome.

Shipley JG, Vandergaast R, Deng L, Mariuzza RA, Fredericksen BL.

Virology. 2012 Oct 10;432(1):232-8. doi: 10.1016/j.virol.2012.06.009. Epub 2012 Jul 7.

11.

How flaviviruses activate and suppress the interferon response.

Muñoz-Jordán JL, Fredericksen BL.

Viruses. 2010 Feb;2(2):676-91. doi: 10.3390/v2020676. Epub 2010 Feb 23.

12.

Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1.

Fredericksen BL, Keller BC, Fornek J, Katze MG, Gale M Jr.

J Virol. 2008 Jan;82(2):609-16. Epub 2007 Oct 31.

13.

Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence.

Keller BC, Fredericksen BL, Samuel MA, Mock RE, Mason PW, Diamond MS, Gale M Jr.

J Virol. 2006 Oct;80(19):9424-34.

15.
16.

Inhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virus.

Fredericksen BL, Wei BL, Yao J, Luo T, Garcia JV.

J Virol. 2002 Nov;76(22):11440-6.

17.

Nef: agent of cell subversion.

Arora VK, Fredericksen BL, Garcia JV.

Microbes Infect. 2002 Feb;4(2):189-99. Review.

PMID:
11880052
18.

Human immunodeficiency virus type 1 Nef-induced CD4 cell surface downregulation is inhibited by ikarugamycin.

Luo T, Fredericksen BL, Hasumi K, Endo A, Garcia JV.

J Virol. 2001 Mar;75(5):2488-92.

19.

Lentivirus Nef specifically activates Pak2.

Arora VK, Molina RP, Foster JL, Blakemore JL, Chernoff J, Fredericksen BL, Garcia JV.

J Virol. 2000 Dec;74(23):11081-7.

Supplemental Content

Loading ...
Support Center